Elsayed I Salim Selected Research

Hyperplasia

12/2004	Lack of carcinogenicity of enzymatically modified isoquercitrin in F344/DuCrj rats.
12/2003	Induction of glutathione S-transferase placental form positive foci in liver and epithelial hyperplasia in urinary bladder, but no tumor development in male Fischer 344 rats treated with monomethylarsonic acid for 104 weeks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elsayed I Salim Research Topics

Disease

24	Neoplasms (Cancer) 05/2024 - 09/2002
19	Carcinogenesis 01/2019 - 01/2003
8	Aberrant Crypt Foci 09/2020 - 09/2002
6	Colonic Neoplasms (Colon Cancer) 09/2020 - 01/2003
4	Breast Neoplasms (Breast Cancer) 05/2024 - 09/2018
4	Body Weight (Weight, Body) 01/2011 - 12/2003
3	Hepatocellular Carcinoma (Hepatoma) 04/2021 - 09/2017
3	Carcinoma (Carcinomatosis) 08/2008 - 01/2005
2	Liver Neoplasms (Liver Cancer) 05/2024 - 09/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 02/2023
2	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2004
2	Infections 03/2018 - 08/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2008 - 01/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2006 - 04/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 05/2005 - 01/2005
2	Fibrosis (Cirrhosis) 05/2005 - 01/2005
2	Hyperplasia 12/2004 - 12/2003
1	Endometrial Neoplasms (Endometrial Cancer) 08/2022
1	Uterine Neoplasms (Uterine Cancer) 08/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2018
1	Persistent Infection 03/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Polyps 01/2012
1	Colonic Polyps 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 01/2012
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2012
1	Schistosomiasis (Bilharziasis) 08/2008
1	Hemorrhage 01/2008

Drug/Important Bio-Agent (IBA)

6	Dimenhydrinate (DMH)FDA LinkGeneric 01/2019 - 12/2003
6	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 01/2019 - 12/2003
5	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 08/2004
5	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2017 - 12/2003
4	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2016
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016 - 12/2003
4	CarcinogensIBA 09/2010 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 05/2005
3	Histone Deacetylase InhibitorsIBA 04/2021 - 03/2004
3	Messenger RNA (mRNA)IBA 09/2018 - 03/2004
3	8-Hydroxy-2'-DeoxyguanosineIBA 08/2008 - 09/2002
3	ArsenicIBA 02/2006 - 02/2003
3	4- (4- cyclohexyl- 2- methyloxazol- 5- yl)- 2- fluorobenzenesulfonamideIBA 01/2005 - 12/2003
2	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 01/2024
2	Gemcitabine FDA Link 01/2024 - 01/2022
2	Bee Venoms (Bee Venom)IBA 01/2024 - 09/2018
2	piperineIBA 01/2024 - 09/2018
2	Tamoxifen FDA LinkGeneric 01/2024 - 09/2018
2	HesperidinIBA 01/2024 - 09/2018
2	GlucocorticoidsIBA 04/2021 - 01/2021
2	trichostatin A (A 300)IBA 04/2021 - 01/2021
2	theasinensin AIBA 04/2021 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021 - 01/2021
2	MethyltransferasesIBA 04/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2021 - 01/2021
2	Celecoxib (Celebrex)FDA Link 01/2019 - 01/2016
2	Therapeutic UsesIBA 03/2018 - 09/2017
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2017 - 04/2006
2	Volatile Oils (Essential Oils)IBA 09/2010 - 01/2003
2	Keratins (Keratin)IBA 01/2006 - 08/2004
2	AzoxymethaneIBA 07/2005 - 07/2004
2	CollagenIBA 05/2005 - 01/2005
2	Thioacetamide (Thioacetamid)IBA 05/2005 - 01/2005
2	monomethylarsonic acid (MSMA)IBA 08/2004 - 12/2003
1	LimoneneIBA 05/2024
1	Atorvastatin (Lipitor)FDA Link 01/2024
1	Angiogenesis InhibitorsIBA 02/2023
1	Bevacizumab (Avastin)FDA Link 02/2023
1	HydrogelsIBA 02/2023
1	bee pollen extractIBA 02/2023
1	MicroRNAs (MicroRNA)IBA 08/2022
1	Urethane (Ethyl Carbamate)IBA 01/2022
1	Butylated Hydroxytoluene (BHT)IBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	balanitosideIBA 01/2022
1	ChitosanIBA 12/2018
1	Ferrosoferric Oxide (Magnetite)FDA Link 12/2018
1	Methotrexate (Mexate)FDA LinkGeneric 12/2018
1	IronIBA 12/2018
1	Free RadicalsIBA 09/2017
1	proanthocyanidinIBA 09/2017
1	Surface Antigens (Surface Antigen)IBA 01/2016
1	Epithelial Cell Adhesion MoleculeIBA 01/2016
1	AntioxidantsIBA 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	Propolis (Bee Bread)IBA 01/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013
1	allyl sulfideIBA 01/2012
1	amsonic acid (DAS)IBA 01/2012
1	Linseed Oil (Flaxseed Oil)IBA 01/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008
1	Genetic Markers (Genetic Marker)IBA 08/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2008
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2008
1	Mastic ResinIBA 03/2007
1	Transforming Growth Factor alpha (TGF-alpha)IBA 04/2006

Therapy/Procedure

7	Therapeutics 05/2024 - 03/2004
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2015
2	Chemoprevention 01/2015 - 07/2004
1	Heterologous Transplantation (Xenotransplantation) 01/2024
1	Traditional Medicine (Folk Remedies) 01/2022
1	Immunotherapy 01/2013